Compagnie Lombard Odier SCmA Sells 575 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Compagnie Lombard Odier SCmA decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 19.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,400 shares of the exchange traded fund’s stock after selling 575 shares during the quarter. Compagnie Lombard Odier SCmA’s holdings in SPDR S&P Biotech ETF were worth $237,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Scarborough Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth $32,000. ORG Partners LLC bought a new position in SPDR S&P Biotech ETF during the second quarter valued at approximately $40,000. Resources Management Corp CT ADV grew its holdings in SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after buying an additional 138 shares in the last quarter. SOA Wealth Advisors LLC. grew its holdings in SPDR S&P Biotech ETF by 79.8% during the 1st quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock valued at $57,000 after buying an additional 265 shares in the last quarter. Finally, Lynx Investment Advisory bought a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $58,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $98.68 on Monday. The stock has a 50 day moving average price of $98.54 and a 200-day moving average price of $94.17. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The company has a market capitalization of $7.52 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.